AptaTargets

AptaTargets Overview

Founded 2014
Founded
Status Private
Latest Deal Type Grant
Latest Deal Amount $4.1M
Latest Deal Amount
Investors 4

AptaTargets General Information

Description

Developer of an innovative molecules using aptamer technology. The company specializes in aptamers, DNA or RNA molecules that can recognize and bond with specific therapeutic targets and are an alternative to antibodies, enabling users to reduce cerebral inflammation caused by stroke or myocardial infarction, autoimmune diseases and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Avenida Cardenal Herrera Oria, 298
  • 28035 Madrid
  • Spain
+34 910 00 00 00

AptaTargets Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AptaTargets Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Dec-2018 $4.1M 00.000 Completed Clinical Trials - Phase 2
3. Early Stage VC 17-May-2017 00.000 00.000 Completed Clinical Trials - Phase 2
2. Grant 29-Dec-2015 Completed Product Development
1. Early Stage VC 01-May-2015 Completed Product Development

AptaTargets Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Exonate Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000 - 000 00000
0000000 0000000000 Venture Capital-Backed San Mateo, CA 00 00000 00000000000 00000
0000000 0000000000 Venture Capital-Backed Nijmegen, Netherlands 00 000.00 0000000000 0 000.00
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 00000000 00.000

AptaTargets Executive Team (3)

Name Title Board Seat Contact Info
David Segarra Co-Founder, Chief Executive Officer & President
Eugenia Zarabozo Co-Founder & Chief Financial Officer
Macarena Jiménez Ph.D CSO

AptaTargets Investors (4)

To view AptaTargets‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ministry of Science and Innovation Government 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0
Ministerio de Economía, Industria y Competitividad Government 000 0000 000000 0
Caixa Capital Risc Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial